Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic effects

Glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) agonists have emerged as treatment options for type 2 diabetes mellitus (T2DM). GLP-1R signals through G-protein-dependent, and G-protein-independent pathways by engaging the scaffold protein β-arrestin; preferential signalling of ligands through one...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hongkai, Sturchler, Emmanuel, Zhu, Jiang, Nieto, Ainhoa, Cistrone, Philip A., Xie, Jia, He, LinLing, Yea, Kyungmoo, Jones, Teresa, Turn, Rachel, Di Stefano, Peter S., Griffin, Patrick R., Dawson, Philip E., McDonald, Patricia H., Lerner, Richard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686834/
https://www.ncbi.nlm.nih.gov/pubmed/26621478
http://dx.doi.org/10.1038/ncomms9918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686834/
https://www.ncbi.nlm.nih.gov/pubmed/26621478
http://dx.doi.org/10.1038/ncomms9918

Ejemplares similares